Biomol Ther.
2025 Jan;33(1):231-232. 10.4062/biomolther.2024.005.
Erratum to "Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein"
- Affiliations
-
- 1Department of Microbiology, College of Medicine, Hallym University, Chuncheon 24252,
- 2College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826,
- 3Institute of Medical Science, College of Medicine, Hallym University, Chuncheon 24252,
- 4Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Republic of Korea
- 5Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-hofuf 31982, Saudi Arabia
- 6Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh 33516, Egypt
- KMID: 2563823
- DOI: http://doi.org/10.4062/biomolther.2024.005
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein
- Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2
- Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant
- Clinical Usefulness of SARS-CoV-2 Antibody Test
- Analysis of SARS-CoV-2 Mutations after Nirmatrelvir Treatment in a Lung Cancer Xenograft Mouse Model
